Featured Conference
4th Annual Forum on Generic Drugs
November 17-18, 2004 Washington, DC
Visit the conference website for more information and to register.
Rave Reviews from Previous Generic Drugs Attendees:
Provided important information and actionable tasks to target the branded pharmaceutical industry.
— Beyat Christen, Senior Consultant, Davinci Healthcare Partners
The Generic Drugs Conference is an essential source for current issues impacting the generic industry.
— Charles Moore, Vice President, Business Development, Altana Inc.
By 2005, analysts project that the generic pharmaceutical products will have annual sales in excess of $22 billion. In the next 10 years, twenty blockbuster drugs, with sales greater than $500 million, are scheduled to lose patent or market exclusivity. There is increasing presence of managed care and other cost-containment efforts in the U.S. and other countries, and increasing numbers of prescriptions filled with less expensive generic alternatives. All these factors are driving the generic drug industry.
Attend CBIs 4th Annual Forum on Generic Drugs to gain a comprehensive look at the important issues impacting todays Generics Industry and hear insights from industry leaders, regulatory experts and Congressional representatives.
This conference gives you up to date information from industry experts in the following areas:
-
Generic Biologics
-
New legislation and regulations
-
Understand branded strategies
-
Generic inroads into blockbusters
-
Patent assessments
For more information or to register, please contact the Center for Business Intelligence toll free by phone at 1/800-817-8601 or via e-mail at cbireg@cbinet.com
Visit the conference website for more information and to register.
